Teva

Nearly ten years ago a class action suit compromise was approved, in which Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)agreed to start publishing on an annual basis the individual remuneration paid to its…

Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Kåre Schultz earned $107 million during his term as head of the Israeli company between December 2017 and the end of 2022. During 2022 his…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is preparing for debt recycling measures. The company announced today plans to issue $2.06 billion of sustainability-linked senior notes and at the same time…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) ended 2022 with revenue of $14.9 billion, in the lower range of the guidance provided in the final quarter. In the fourth quarter of 2022, revenue was $3.9…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported today that it has either already settled with or confirmed participation from 48 of the 50 US states and that it would continue to pursue participation…

The U.S. Food and Drug Administration’s (FDA) regulatory review is anticipated to be completed in the second half of 2023Stelara® (ustekinumab) is prescribed to treat a variety of inflammatory conditions REYKJAVIK, Iceland and…

Pune, Dec. 15, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global central nervous system treatment market is expected to clock US$ 191.01 billion by 2030 and to grow at a CAGR of 9.10%…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Kare Schultz will step down at the end of next month, sooner than expected. Teva today announced the appointment of Richard Francis as president and…

AP NEW YORK (AP) — New York will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic, the largest amount secured from an opioid…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported results for the quarter ended September 30, 2022. Revenue for the second quarter was $3.6 billion, below the analysts' estimates of $3.8 billion.…